Percutaneous Coronary Intervention
Showing 26 - 50 of 217
Primary Percutaneous Coronary Intervention Guidance Using
Active, not recruiting
- ST Elevation Myocardial Infarction
- +5 more
-
Rotterdam, NetherlandsErasmus University Medical Center
Jan 16, 2023
ST-Segment Elevation Myocardial Infarction, Multivessel Coronary Artery Disease, Percutaneous Coronary Intervention Trial (FAST
Not yet recruiting
- ST-Segment Elevation Myocardial Infarction
- +2 more
- FAST Technique
- Angiography
- (no location specified)
Jan 1, 2023
Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Cona, Latina (Microcatheter-derived FFR,
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Microcatheter-derived FFR
- +2 more
-
Cona, Ferrara, Italy
- +1 more
Dec 23, 2022
Coronary Artery Disease, Myocardial Ischaemia, Coronary Circulation Trial in Beijing (QFR, Angiography)
Active, not recruiting
- Coronary Artery Disease
- +4 more
- QFR
- Angiography
-
Beijing, Beijing, ChinaFu Wai Hospital, National Center for Cardiovascular Diseases, Ch
Dec 16, 2022
Percutaneous Coronary Intervention, Coronary Heart Disease, Robotic Surgical Procedures Trial (ALLVAS® robotic-assisted PCI)
Not yet recruiting
- Percutaneous Coronary Intervention
- +2 more
- ALLVAS® robotic-assisted PCI
- (no location specified)
Dec 7, 2022
Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Beijing (Aspirin + Clopidogrel +
Not yet recruiting
- Coronary Artery Disease
- +2 more
- Aspirin + Clopidogrel + Rivaroxaban
- Aspirin + Clopidogrel
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences, Fuwai Hospital
Dec 5, 2022
Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Seoul (Percutaneous coronary intervention)
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Percutaneous coronary intervention
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 15, 2022
Coronary Disease, Percutaneous Coronary Intervention, Exercise Test Trial in New Haven (No study intervention)
Enrolling by invitation
- Coronary Disease
- +4 more
- No study intervention
-
New Haven, ConnecticutYale University School of Medicine - Section of Cardiology
Nov 9, 2022
ST Elevation Myocardial Infarction, Coronary Artery Disease, Distal Transradial Artery Trial in Charleroi, Patras (Coronary
Not yet recruiting
- ST Elevation Myocardial Infarction
- +6 more
- Coronary angiography +/- percutaneous coronary intervention
-
Charleroi, Belgium
- +1 more
Nov 8, 2022
ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, No-Reflow Phenomenon Trial in Tomsk (Standard therapy,
Active, not recruiting
- ST Elevation Myocardial Infarction
- +2 more
- Standard therapy
- +3 more
-
Tomsk, Tomsk Region, Russian FederationCardiology Research Institute, Tomsk NRMC
Oct 31, 2022
STEMI, Multi Vessel Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Xiamen (In-hospital staged PCI,
Recruiting
- STEMI
- +2 more
- In-hospital staged PCI
- Out-hospital staged PCI
-
Xiamen, Fujian, ChinaXiamen Cardiovascular Hospital Xiamen University
Oct 29, 2022
Percutaneous Coronary Intervention, Coronary Artery Calcification, Coronary Artery Disease Trial in Denmark (Lithoplasty,
Recruiting
- Percutaneous Coronary Intervention
- +2 more
- Lithoplasty
- Conventional
-
Gentofte, Copenhagen, Denmark
- +5 more
Oct 26, 2022
Acute Coronary Syndrome, ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention Trial in Beijing (Intrathrombus
Recruiting
- Acute Coronary Syndrome
- +2 more
- Intrathrombus Thrombolysis During Primary PCI
- Aspiration Thrombectomy During Primary PCI
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Sep 22, 2022
Cardiovascular Diseases, Percutaneous Coronary Intervention Trial in Hamilton (Higher Dose UFH, Lower Dose UFH)
Recruiting
- Cardiovascular Diseases
- Percutaneous Coronary Intervention
- Higher Dose UFH
- Lower Dose UFH
-
Hamilton, Ontario, CanadaHamilton Health Sciences, General Hospital
Sep 19, 2022
Acute Coronary Syndrome, Percutaneous Coronary Intervention Trial in Hangzhou (Standard-DAPT of Ticagrelor plus aspirin,
Not yet recruiting
- Acute Coronary Syndrome
- Percutaneous Coronary Intervention
- Standard-DAPT of Ticagrelor plus aspirin
- Sequential monotherapy of Ticagrelor and clopidogrel
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
Sep 20, 2022
Percutaneous Coronary Intervention, Anxiety, Hemodynamics Trial in Karaman (Music, Stress ball)
Recruiting
- Percutaneous Coronary Intervention
- +2 more
- Music
- Stress ball
-
Karaman, TurkeyKaraman Provincial Health Directorate Karamanoğlu Mehmetbey Univ
Aug 22, 2022
Acute Myocardial Infarction, Acute Coronary Syndrome, Stable Angina Pectoris Trial in Minneapolis, Rochester (Center-Based
Recruiting
- Acute Myocardial Infarction
- +4 more
- Center-Based Cardiac Rehab
- +2 more
-
Minneapolis, Minnesota
- +1 more
Aug 19, 2022
No-Reflow Phenomenon, Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Seoul (Nicorandil, Placebo)
Not yet recruiting
- No-Reflow Phenomenon
- +2 more
- Nicorandil
- Placebo
-
Seoul, Korea, Republic ofKorea University Anam Hospital
Aug 16, 2022
Acute Coronary Syndrome, Acute Myocardial Infarction, Coronary Artery Disease Trial in Spain (Clopidogrel, Previous treatment)
Recruiting
- Acute Coronary Syndrome
- +3 more
- Clopidogrel
- Previous treatment
-
El Palmar, Murcia, Spain
- +14 more
Aug 5, 2022
Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention Trial in Nanjing (Placebo plus high-intensity
Not yet recruiting
- Acute Coronary Syndrome
- +3 more
- Placebo plus high-intensity statin
- PCSK 9 Inhibitor plus high-intensity statin
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Aug 1, 2022
Percutaneous Coronary Intervention Trial in United States (Iopamidol, adenosine, Navvus® Catheter)
Active, not recruiting
- Percutaneous Coronary Intervention
- Iopamidol
- +3 more
-
Long Beach, California
- +4 more
Jul 27, 2022
ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention Trial in Shanghai (Nicorandil, Placebo)
Recruiting
- ST Elevation Myocardial Infarction
- Percutaneous Coronary Intervention
- Nicorandil
- Placebo
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Jul 26, 2022
Transcatheter Aortic Valve Replacement, Percutaneous Coronary Intervention Trial in Rotterdam (activated partial thrombin time)
Recruiting
- Transcatheter Aortic Valve Replacement
- Percutaneous Coronary Intervention
- activated partial thrombin time
-
Rotterdam, Zuid Holland, NetherlandsErasmus University Medical Center
Jul 25, 2022
Cardiac Arrest, Out-Of-Hospital, Angiography, Percutaneous Coronary Intervention Trial in Denmark (Acute CAG)
Recruiting
- Cardiac Arrest, Out-Of-Hospital
- +3 more
- Acute CAG
-
Aalborg, Denmark
- +4 more
Jul 22, 2022
Percutaneous Coronary Intervention Trial in Napoli (Cangrelor)
Recruiting
- Percutaneous Coronary Intervention
-
Napoli, ItalyUniversity Federico II of Naples
Jul 25, 2022